# An Atypical Presentation of Cutaneous Angiosarcoma: A Diagnostic Challenge in an End-Stage Renal Disease Patient

**Authors:** Sydney L McManus, Ty Theriot, Kayla Rykiel, Allison Pinner, Christopher Haas

PMC · DOI: 10.7759/cureus.102076 · 2026-01-22

## TL;DR

This case report describes a rare and aggressive skin cancer that presented atypically in a patient with kidney disease, highlighting the need for careful diagnosis.

## Contribution

The paper presents a unique case of angiosarcoma without traditional risk factors, emphasizing diagnostic challenges in similar patients.

## Key findings

- The patient's symptoms were initially mistaken for calciphylaxis due to her kidney disease history.
- The case suggests malignant transformation of chronic venous insufficiency as a possible cause.
- Angiosarcoma should be considered in the differential diagnosis of atypical skin lesions.

## Abstract

Angiosarcomas are rare and highly aggressive malignant vascular tumors that are associated with a very poor prognosis. The rarity of the disease, its variable clinical presentations, and differing pathophysiologic mechanisms make diagnosing angiosarcoma a challenge. This case report details a 75-year-old woman with an atypical presentation of cutaneous angiosarcoma in the absence of traditional risk factors. Due to the patient’s history of end-stage renal disease, her initial presentation was highly suspicious for cutaneous calciphylaxis of the left lower extremity. After a thorough workup, this patient likely had malignant transformation of her chronic venous insufficiency. This case underscores the necessity for healthcare providers to consider angiosarcoma in the differential diagnosis of atypical, persistent violaceous nodules and plaques, even in the absence of classic risk factors such as radiation exposure, chronic lymphedema, genetic syndromes, and certain linked carcinogens. A high index of suspicion, combined with timely diagnostic interventions, is vital to address this aggressive malignancy effectively.

## Linked entities

- **Diseases:** angiosarcoma (MONDO:0003022), end-stage renal disease (MONDO:0004375), calciphylaxis (MONDO:0017215), chronic venous insufficiency (MONDO:0000492)

## Full-text entities

- **Genes:** S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, MLANA (melan-A) [NCBI Gene 2315] {aka MART-1, MART1}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}
- **Diseases:** infections (MESH:D007239), calciphylaxis (MESH:D002115), ESRD (MESH:D007676), blisters (MESH:D001768), arteriovenous fistula (MESH:D001164), extremity (MESH:C563475), cellulitis (MESH:D002481), scalp lesion (MESH:D004476), Renal impairment (MESH:D007674), heart failure (MESH:D006333), ecchymoses (MESH:D004438), edema (MESH:D004487), chronic venous insufficiency (MESH:D014689), malignancy (MESH:D009369), lymphedema (MESH:D008209), pain (MESH:D010146), inflammatory (MESH:D007249), venous disease (MESH:D004194), trauma (MESH:D014947), hematomas (MESH:D006406), melanoma (MESH:D008545), hyperlipidemia (MESH:D006949), primary angiosarcoma of the breast (MESH:C536368), venous stasis (MESH:D054070), Angiosarcomas (MESH:D006394), Kaposi sarcoma (MESH:D012514), squamous cell carcinoma (MESH:D002294), genetic syndromes (MESH:D030342), soft tissue sarcomas (MESH:D012509), tumorigenesis (MESH:D063646), venous stasis ulcers (MESH:D014647), cutaneous (MESH:D018366), hypoxic (MESH:D002534), cutaneous lesions (MESH:D009059)
- **Chemicals:** arsenic (MESH:D001151), vinyl chloride (MESH:D014752), thorium dioxide (MESH:D013911)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924670/full.md

---
Source: https://tomesphere.com/paper/PMC12924670